EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation

Tiantian Qi, Haotian Qin, Fei Yu, Zimeng Zhou, Yingqi Chen, Peng Liu, Hui Zeng, Jian Weng

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl36233 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, 2025. Written by Tiantian Qi and 7 co-authors. Institution: Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technolog…. Major MEDLINE topics: Muscular Atrophy, MAP Kinase Signaling System, Muscle, Skeletal, RNA, Long Noncoding. Cited 2 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Shenzhen Key Medical Discipline Construction Fund, Sanming Project of Medicine in Shenzhen.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Skeletal muscle atrophy is a common musculoskeletal disorder that significantly reduces patient quality of life. Long non-coding RNA (lncRNA) XLOC_015548 has been identified as a pivotal regulator of C2C12 myoblast proliferation and differentiation. However, its role in mitigating denervation-induced muscle atrophy and the underlying mechanisms remain unclear.

Methods

We employed lentiviral-mediated stable expression of XLOC_015548 in C2C12 myoblasts and skeletal muscle-specific XLOC_015548-edited mouse models to investigate the function of this lncRNA. Muscle atrophy models were established in vitro by glucocorticoid-induced atrophy with dexamethasone (DEX) and in vivo by sciatic nerve transection-induced denervation. The MEK inhibitor U0126 was used to assess the role of the growth arrest and DNA damage-inducible 45 gamma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (Gadd45g/MEK/ERK) signaling pathway.

Results

Overexpression of XLOC_015548 significantly activated the MEK/ERK signaling pathway (p < 0.05) by downregulating Gadd45g expression (p < 0.05) and promoting its cytoplasmic localization, thereby enhancing cell proliferation and myotube formation. Furthermore, XLOC_015548 reduced the level of reactive oxygen species (ROS) (p < 0.01), stabilized the mitochondrial membrane potential, and alleviated DEX-induced oxidative stress. These protective effects were partially reversed by U0126, confirming the involvement of the MEK/ERK pathway. Skeletal muscle-specific overexpression of XLOC_015548 in vivo significantly reduced denervation-induced muscle atrophy (q < 0.05) and increased the muscle fiber cross-sectional area.

Conclusion

XLOC_015548 plays a critical role in promoting myogenic differentiation and protecting against muscle atrophy by regulating Gadd45g expression, activating the MEK/ERK signaling pathway, and reducing oxidative stress. These findings underscore the therapeutic potential of XLOC_015548 in skeletal muscle atrophy, and provide a foundation for lncRNA-based treatment strategies.

Subjects

MeSH terms (MEDLINE)

Muscular AtrophyMAP Kinase Signaling SystemMuscle, SkeletalRNA, Long NoncodingAnimalsMiceOxidation-ReductionCell LineCell ProliferationMaleCell DifferentiationMice, Inbred C57BLReactive Oxygen SpeciesOxidative Stress

Author keywords

XLOC_015548long non-coding RNAmyogenic differentiationoxidative stressskeletal muscle atrophy

Substances

RNA, Long NoncodingReactive Oxygen Species

Authors and institutions

  • Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, 518036 Shenzhen, Guangdong, China.
  • National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, 518036 Shenzhen, Guangdong, China.
  • Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, 518036 Shenzhen, Guangdong, China.
  • Department of Spine Surgery, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, 518035 Shenzhen, Guangdong, China.
  • Department of Orthopedic Trauma, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, 518035 Shenzhen, Guangdong, China.

Funding

  • National Natural Science Foundation of China
  • Shenzhen Key Medical Discipline Construction Fund
  • Sanming Project of Medicine in Shenzhen
  • Shenzhen Science and Technology Program
  • Guangdong Basic and Applied Basic Research Foundation
  • The Scientific Research Foundation of PEKING UNIVERSITY SHENZHEN HOSPITAL

Cite

APA

Qi, T., Qin, H., Yu, F., Zhou, Z., Chen, Y., Liu, P., Zeng, H., & Weng, J. (2025). XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl36233

Vancouver

Qi T, Qin H, Yu F, Zhou Z, Chen Y, Liu P, et al. XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl36233

BibTeX
@article{Qi2025,
  author = {Qi, Tiantian and Qin, Haotian and Yu, Fei and Zhou, Zimeng and Chen, Yingqi and Liu, Peng and Zeng, Hui and Weng, Jian},
  title = {XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl36233}
}
Start for free →